Stocktoria
CATALYST PHARMACEUTICALS, INC. CPRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2006-11-08
CATALYST PHARMACEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 43.8% | 39.7% | 21.8% | 47.5% | 37.2% |
| Net margin | 36.4% | 33.3% | 17.9% | 38.8% | 28.0% |
| FCF margin | 35.4% | 48.7% | 36.0% | 54.2% | 42.1% |
| Return on assets | 19.4% | 19.2% | 15.2% | 22.1% | 16.6% |
| Return on equity | 22.5% | 22.5% | 18.4% | 27.7% | 19.1% |
| Current ratio | 6.08 | 5.17 | 2.88 | 5.57 | 7.76 |
| Revenue growth | 19.8% | 23.5% | 85.9% | 52.1% | 18.3% |
Source: SEC EDGAR filings · CIK 0001369568 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.